Cargando…

A comparative analysis of national HIV policies in six African countries with generalized epidemics

OBJECTIVE: To compare national human immunodeficiency virus (HIV) policies influencing access to HIV testing and treatment services in six sub-Saharan African countries. METHODS: We reviewed HIV policies as part of a multi-country study on adult mortality in sub-Saharan Africa. A policy extraction t...

Descripción completa

Detalles Bibliográficos
Autores principales: Church, Kathryn, Kiweewa, Francis, Dasgupta, Aisha, Mwangome, Mary, Mpandaguta, Edith, Gómez-Olivé, Francesc Xavier, Oti, Samuel, Todd, Jim, Wringe, Alison, Geubbels, Eveline, Crampin, Amelia, Nakiyingi-Miiro, Jessica, Hayashi, Chika, Njage, Muthoni, Wagner, Ryan G, Ario, Alex Riolexus, Makombe, Simon D, Mugurungi, Owen, Zaba, Basia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490813/
https://www.ncbi.nlm.nih.gov/pubmed/26170503
http://dx.doi.org/10.2471/BLT.14.147215
Descripción
Sumario:OBJECTIVE: To compare national human immunodeficiency virus (HIV) policies influencing access to HIV testing and treatment services in six sub-Saharan African countries. METHODS: We reviewed HIV policies as part of a multi-country study on adult mortality in sub-Saharan Africa. A policy extraction tool was developed and used to review national HIV policy documents and guidelines published in Kenya, Malawi, South Africa, Uganda, the United Republic of Tanzania and Zimbabwe between 2003 and 2013. Key informant interviews helped to fill gaps in findings. National policies were categorized according to whether they explicitly or implicitly adhered to 54 policy indicators, identified through literature and expert reviews. We also compared the national policies with World Health Organization (WHO) guidance. FINDINGS: There was wide variation in policies between countries; each country was progressive in some areas and not in others. Malawi was particularly advanced in promoting rapid initiation of antiretroviral therapy. However, no country had a consistently enabling policy context expected to increase access to care and prevent attrition. Countries went beyond WHO guidance in certain areas and key informants reported that practice often surpassed policy. CONCLUSION: Evaluating the impact of policy differences on access to care and health outcomes among people living with HIV is challenging. Certain policies will exert more influence than others and official policies are not always implemented. Future research should assess the extent of policy implementation and link these findings with HIV outcomes.